BOCH
RYTM icon

Blue Owl Capital Holdings’s Rhythm Pharmaceuticals RYTM Stock Holding History

Blue Owl Capital Holdings’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.82M Hold
61,455
– – 1.03% 18
2026
Q1 		$5.34M Buy
+61,455
New +$5.98M 1.44% 16

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Blue Owl Capital Holdings's RYTM Position: Q2 2026 in Review

Blue Owl Capital Holdings held its Rhythm Pharmaceuticals (RYTM) position steady in Q2 2026 at 61,455 shares worth $6.82M. The position accounts for 1.03% of the portfolio, ranked #18.

Blue Owl Capital Holdings first reported a position in RYTM in Q1 2026 and has held it in 2 quarters since. 303 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Blue Owl Capital Holdings held 61,455 shares of Rhythm Pharmaceuticals worth $6.82M as of Q2 2026.
  • Blue Owl Capital Holdings left its Rhythm Pharmaceuticals share count unchanged in Q2 2026.
  • Rhythm Pharmaceuticals made up 1.03% of Blue Owl Capital Holdings's portfolio in Q2 2026, its #18 holding.
  • Blue Owl Capital Holdings first reported a position in Rhythm Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 303 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Blue Owl Capital Holdings's 13F filing for Q2 2026, filed 11 Aug 2026.